UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Looking for ways to make money while you sleep? Explore effective methods that can help you generate passive income effortlessly.
27,973 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
IonQ posted full-year revenue of $130 million and a 2026 guidance of $225-245 million, as it leans on defense contrac...
Oil prices rose above $100 a barrel after a large emergency stockpile release. Yet investor fears lingered about supp...
Ulta Beauty shares have tumbled in the wake of earnings, but analysts see a potential entry point. The ulta beauty pr...
Oil breaks $100 again as Middle East tensions flare, lifting energy stocks and reshaping risk-on bets for 2026. Inves...
At ICE X26, MBA President Bob Broeksmit outlined how Trump orders, AI-driven underwriting, and tight housing supply a...
The Federal Reserve decided to keep rates unchanged, citing resilient growth and persistent price pressures. Geopolit...
FCX and NEM beat quarterly estimates, but 2026 headwinds and project timing are shaping whether one stock outperforms...
Regulators deliver a landmark clarification for crypto assets, signaling non-securities for most tokens. But the fram...
The CFTC unveiled an Innovation Task Force to steer policy on crypto, AI, and prediction markets. Regulators aim for ...
IBM’s leadership points to a quicker, clearer regulatory path for mergers and acquisitions, citing the Confluent purc...
Rising energy costs from the Iran conflict are trimming U.S. payroll growth by a running estimate of up to 12,000 job...